Literature DB >> 19557330

The CXXC finger 5 protein is required for DNA damage-induced p53 activation.

Min ZHANG1, RuiPeng WANG, YanYi WANG, FeiCi DIAO, Fei LU, Dong GAO, DanYing CHEN, ZhongHe ZHAI, HongBing SHU.   

Abstract

The tumor suppressor p53 is a critical component of the DNA damage response pathway that induces a set of genes responsible for cell cycle arrest, senescence, apoptosis, and DNA repair. The ataxia telangiectasia mutated protein kinase (ATM) responds to DNA-damage stimuli and signals p53 stabilization and activation, thereby facilitating transactivation of p53 inducible genes and maintainence of genome integrity. In this study, we identified a CXXC zinc finger domain containing protein termed CF5 as a critical component in the DNA damage signaling pathway. CF5 induces p53 transcriptional activity and apoptosis in cells expressing wild type p53 but not in p53-deficient cells. Knockdown of CF5 inhibits DNA damage-induced p53 activation as well as cell cycle arrest. Furthermore, CF5 physically interacts with ATM and is required for DNA damage-induced ATM phosphorylation but not its recruitment to chromatin. These findings suggest that CF5 plays a crucial role in ATM-p53 signaling in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557330     DOI: 10.1007/s11427-009-0083-7

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  13 in total

1.  Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

Authors:  Pamela A Marshall; Zachary Hernandez; Ichiro Kaneko; Tim Widener; Christa Tabacaru; Izayadeth Aguayo; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-14       Impact factor: 4.292

Review 2.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

3.  Genetic determinants of telomere length from 109,122 ancestrally diverse whole-genome sequences in TOPMed.

Authors:  Margaret A Taub; Matthew P Conomos; Rebecca Keener; Kruthika R Iyer; Joshua S Weinstock; Lisa R Yanek; John Lane; Tyne W Miller-Fleming; Jennifer A Brody; Laura M Raffield; Caitlin P McHugh; Deepti Jain; Stephanie M Gogarten; Cecelia A Laurie; Ali Keramati; Marios Arvanitis; Albert V Smith; Benjamin Heavner; Lucas Barwick; Lewis C Becker; Joshua C Bis; John Blangero; Eugene R Bleecker; Esteban G Burchard; Juan C Celedón; Yen Pei C Chang; Brian Custer; Dawood Darbar; Lisa de Las Fuentes; Dawn L DeMeo; Barry I Freedman; Melanie E Garrett; Mark T Gladwin; Susan R Heckbert; Bertha A Hidalgo; Marguerite R Irvin; Talat Islam; W Craig Johnson; Stefan Kaab; Lenore Launer; Jiwon Lee; Simin Liu; Arden Moscati; Kari E North; Patricia A Peyser; Nicholas Rafaels; Christine Seidman; Daniel E Weeks; Fayun Wen; Marsha M Wheeler; L Keoki Williams; Ivana V Yang; Wei Zhao; Stella Aslibekyan; Paul L Auer; Donald W Bowden; Brian E Cade; Zhanghua Chen; Michael H Cho; L Adrienne Cupples; Joanne E Curran; Michelle Daya; Ranjan Deka; Celeste Eng; Tasha E Fingerlin; Xiuqing Guo; Lifang Hou; Shih-Jen Hwang; Jill M Johnsen; Eimear E Kenny; Albert M Levin; Chunyu Liu; Ryan L Minster; Take Naseri; Mehdi Nouraie; Muagututi'a Sefuiva Reupena; Ester C Sabino; Jennifer A Smith; Nicholas L Smith; Jessica Lasky Su; James G Taylor; Marilyn J Telen; Hemant K Tiwari; Russell P Tracy; Marquitta J White; Yingze Zhang; Kerri L Wiggins; Scott T Weiss; Ramachandran S Vasan; Kent D Taylor; Moritz F Sinner; Edwin K Silverman; M Benjamin Shoemaker; Wayne H-H Sheu; Frank Sciurba; David A Schwartz; Jerome I Rotter; Daniel Roden; Susan Redline; Benjamin A Raby; Bruce M Psaty; Juan M Peralta; Nicholette D Palmer; Sergei Nekhai; Courtney G Montgomery; Braxton D Mitchell; Deborah A Meyers; Stephen T McGarvey; Angel Cy Mak; Ruth Jf Loos; Rajesh Kumar; Charles Kooperberg; Barbara A Konkle; Shannon Kelly; Sharon Lr Kardia; Robert Kaplan; Jiang He; Hongsheng Gui; Frank D Gilliland; Bruce D Gelb; Myriam Fornage; Patrick T Ellinor; Mariza de Andrade; Adolfo Correa; Yii-Der Ida Chen; Eric Boerwinkle; Kathleen C Barnes; Allison E Ashley-Koch; Donna K Arnett; Cathy C Laurie; Goncalo Abecasis; Deborah A Nickerson; James G Wilson; Stephen S Rich; Daniel Levy; Ingo Ruczinski; Abraham Aviv; Thomas W Blackwell; Timothy Thornton; Jeff O'Connell; Nancy J Cox; James A Perry; Mary Armanios; Alexis Battle; Nathan Pankratz; Alexander P Reiner; Rasika A Mathias
Journal:  Cell Genom       Date:  2022-01-13

4.  Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.

Authors:  Andrea Kühnl; Peter J M Valk; Mathijs A Sanders; Adam Ivey; Robert K Hills; Ken I Mills; Rosemary E Gale; Martin F Kaiser; Richard Dillon; Melanie Joannides; Amanda Gilkes; Torsten Haferlach; Susanne Schnittger; Estelle Duprez; David C Linch; Ruud Delwel; Bob Löwenberg; Claudia D Baldus; Ellen Solomon; Alan K Burnett; David Grimwade
Journal:  Blood       Date:  2015-03-24       Impact factor: 22.113

5.  The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing.

Authors:  Soung-Hoon Lee; Mi-Yeon Kim; Hyun-Yi Kim; Young-Mi Lee; Heesu Kim; Kyoung Ae Nam; Mi Ryung Roh; Do Sik Min; Kee Yang Chung; Kang-Yell Choi
Journal:  J Exp Med       Date:  2015-06-08       Impact factor: 14.307

6.  Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway.

Authors:  Pelin Yaşar; Gamze Ayaz; Mesut Muyan
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

7.  Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.

Authors:  Shixin Ma; Xiaoling Wan; Zihou Deng; Lei Shi; Congfang Hao; Zhenyuan Zhou; Chun Zhou; Yiyuan Fang; Jinghua Liu; Jing Yang; Xia Chen; Tiantian Li; Aiping Zang; Shigang Yin; Bin Li; Joel Plumas; Laurence Chaperot; Xiaoming Zhang; Guoliang Xu; Lubin Jiang; Nan Shen; Sidong Xiong; Xiaoming Gao; Yan Zhang; Hui Xiao
Journal:  J Exp Med       Date:  2017-04-17       Impact factor: 14.307

8.  Overexpression of CXXC5 is a strong poor prognostic factor in ER+ breast cancer.

Authors:  Lei Fang; Yu Wang; Yang Gao; Xuejun Chen
Journal:  Oncol Lett       Date:  2018-05-07       Impact factor: 2.967

Review 9.  CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling.

Authors:  Xiangyang Xiong; Shuo Tu; Jianbin Wang; Shiwen Luo; Xiaohua Yan
Journal:  J Cell Mol Med       Date:  2018-11-27       Impact factor: 5.310

10.  A CpG island promoter drives the CXXC5 gene expression.

Authors:  Pelin Yaşar; Gizem Kars; Kerim Yavuz; Gamze Ayaz; Çerağ Oğuztüzün; Ecenaz Bilgen; Zeynep Suvacı; Özgül Persil Çetinkol; Tolga Can; Mesut Muyan
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.